Maria Elena Bottazzi
#53,067
Most Influential Person Now
Researcher
Maria Elena Bottazzi's AcademicInfluence.com Rankings
Maria Elena Bottazzimedical Degrees
Medical
#2077
World Rank
#2475
Historical Rank
Epidemiology
#713
World Rank
#743
Historical Rank
Maria Elena Bottazzibiology Degrees
Biology
#2416
World Rank
#3834
Historical Rank
Immunology
#311
World Rank
#323
Historical Rank
Download Badge
Medical Biology
Maria Elena Bottazzi's Degrees
- PhD Microbiology and Immunology University of Texas Medical Branch
- Doctorate Medicine University of Buenos Aires
Why Is Maria Elena Bottazzi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Maria Elena Bottazzi is an American microbiologist, currently Associate Dean of the National School of Tropical Medicine at Baylor College of Medicine, as well as Distinguished Professor of Biology at Baylor University, Waco, Texas. She is editor-in-chief of Springer's Current Tropical Medicine Reports. She and Peter Hotez led the team that designed COVID-19 vaccine Corbevax.
Maria Elena Bottazzi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and Elimination (2008) (665)
- Global economic burden of Chagas disease: a computational simulation model. (2013) (490)
- The SARS-CoV-2 Vaccine Pipeline: an Overview (2020) (449)
- Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention (2020) (221)
- α5β1 Integrin Controls Cyclin D1 Expression by Sustaining Mitogen-activated Protein Kinase Activity in Growth Factor-treated Cells (1999) (212)
- Hookworm: “The Great Infection of Mankind” (2005) (202)
- Disproportionate impact of the COVID-19 pandemic on immigrant communities in the United States (2020) (196)
- Chagas Disease: “The New HIV/AIDS of the Americas” (2012) (196)
- Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals (2005) (181)
- Status of vaccine research and development of vaccines for leishmaniasis. (2016) (170)
- Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. (2003) (153)
- COVID-19 vaccine design: the Janus face of immune enhancement (2020) (150)
- Regulation of P21cip1 Expression by Growth Factors and the Extracellular Matrix Reveals a Role for Transient ERK Activity in G1 Phase (1999) (146)
- Vaccination with Recombinant Aspartic Hemoglobinase Reduces Parasite Load and Blood Loss after Hookworm Infection in Dogs (2005) (136)
- An Unfolding Tragedy of Chagas Disease in North America (2013) (131)
- New vaccines for neglected parasitic diseases and dengue. (2013) (130)
- Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome (2012) (125)
- Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19 (2020) (114)
- The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation (2005) (113)
- Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects (2012) (112)
- Vaccination of dogs with a recombinant cysteine protease from the intestine of canine hookworms diminishes the fecundity and growth of worms. (2004) (109)
- The BENEFIT Trial: Where Do We Go from Here? (2016) (109)
- The Global Economic and Health Burden of Human Hookworm Infection (2016) (108)
- Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate (2014) (107)
- Neglected Tropical Diseases among the Association of Southeast Asian Nations (ASEAN): Overview and Update (2015) (106)
- The Human Hookworm Vaccine (2013) (105)
- Role of viral regulatory and accessory proteins in HIV-1 replication. (2004) (105)
- Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. (1999) (102)
- Ancylostoma caninum MTP-1, an Astacin-Like Metalloprotease Secreted by Infective Hookworm Larvae, Is Involved in Tissue Migration (2006) (101)
- New technologies for the control of human hookworm infection. (2006) (101)
- The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement (2020) (100)
- Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. (2005) (98)
- Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly (2020) (95)
- Human Intestinal Parasite Burden and Poor Sanitation in Rural Alabama (2017) (94)
- Advancing a vaccine to prevent human schistosomiasis. (2016) (94)
- Protein Profile of Tax-associated Complexes* (2004) (93)
- Toxocariasis in North America: A Systematic Review (2014) (89)
- The Lancet Commission on lessons for the future from the COVID-19 pandemic (2022) (88)
- Molecular Cloning, Biochemical Characterization, and Partial Protective Immunity of the Heme-Binding Glutathione S-Transferases from the Human Hookworm Necator americanus (2010) (87)
- Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics (2021) (83)
- Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate (2017) (82)
- An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection (2009) (81)
- The extracellular matrix and mitogenic growth factors control G1 phase cyclins and cyclin-dependent kinase inhibitors. (1997) (68)
- COVID-19 vaccines: neutralizing antibodies and the alum advantage (2020) (67)
- Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs. (2006) (67)
- Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America (2019) (63)
- Neglected tropical diseases in Central America and Panama: review of their prevalence, populations at risk and impact on regional development. (2014) (62)
- Modeling the economic value of a Chagas’ disease therapeutic vaccine (2012) (61)
- Status of vaccine research and development of vaccines for Chagas disease. (2016) (60)
- Advancing a multivalent ‘Pan-anthelmintic’ vaccine against soil-transmitted nematode infections (2014) (57)
- Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen (2018) (57)
- Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement (2020) (56)
- The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells (2004) (56)
- Innovation for the 'bottom 100 million': eliminating neglected tropical diseases in the Americas. (2013) (55)
- The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. (2013) (53)
- Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults (2017) (53)
- Developing a low-cost and accessible COVID-19 vaccine for global health (2020) (53)
- New Vaccines for the World's Poorest People. (2016) (49)
- Functional consequences of cyclin D1/BRCA1 interaction in breast cancer cells (2007) (49)
- Texas and Mexico: Sharing a Legacy of Poverty and Neglected Tropical Diseases (2012) (47)
- A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease (2016) (46)
- Operation Warp Speed: implications for global vaccine security (2021) (44)
- Expression, Immunogenicity, Histopathology, and Potency of a Mosquito-Based Malaria Transmission-Blocking Recombinant Vaccine (2012) (43)
- Vaccine-Linked Chemotherapy Improves Benznidazole Efficacy for Acute Chagas Disease (2018) (42)
- Human anthelminthic vaccines: Rationale and challenges. (2016) (39)
- Distinct Effects of Mitogens and the Actin Cytoskeleton on CREB and Pocket Protein Phosphorylation Control the Extent and Timing of Cyclin A Promoter Activity (2001) (39)
- Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement (2020) (38)
- Whole Inactivated Virus and Protein-Based COVID-19 Vaccines. (2021) (38)
- Advancing the Development of a Human Schistosomiasis Vaccine. (2019) (37)
- Correcting COVID-19 vaccine misinformation (2021) (37)
- Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate (2020) (36)
- Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice. (2015) (36)
- Onchocerca volvulus: The Road from Basic Biology to a Vaccine. (2018) (36)
- SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice (2020) (35)
- Advancing a vaccine to prevent hookworm disease and anemia. (2016) (34)
- Expression at a 20L scale and purification of the extracellular domain of the Schistosoma mansoni TSP-2 recombinant protein (2013) (34)
- The impact of concurrent and treated Ancylostoma ceylanicum hookworm infections on the immunogenicity of a recombinant hookworm vaccine in hamsters. (2006) (34)
- An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice (2021) (34)
- Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development (2018) (34)
- The Unfinished Public Health Agenda of Chagas Disease in the Era of Globalization (2009) (33)
- Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model. (2014) (33)
- Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease (2017) (33)
- A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection (2019) (33)
- A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates (2021) (32)
- The Onchocerciasis Vaccine for Africa—TOVA—Initiative (2015) (32)
- SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice (2021) (32)
- Development of chagas cardiac manifestations among Texas blood donors. (2015) (32)
- Production of recombinant TSA-1 and evaluation of its potential for the immuno-therapeutic control of Trypanosoma cruzi infection in mice (2018) (32)
- Reduction of Worm Fecundity and Canine Host Blood Loss Mediates Protection against Hookworm Infection Elicited by Vaccination with Recombinant Ac-16 (2007) (31)
- Lessons along the Critical Path: Developing Vaccines against Human Helminths. (2018) (31)
- Trypanosoma cruzi screening in Texas blood donors, 2008–2012 (2014) (31)
- Calling for rapid development of a safe and effective MERS vaccine (2014) (30)
- IgG Induced by Vaccination With Ascaris suum Extracts Is Protective Against Infection (2018) (30)
- Global COVID-19 Efforts as the Platform to Achieving the Sustainable Development Goals (2020) (29)
- Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen. (2012) (29)
- Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic (2021) (28)
- Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate (2014) (28)
- A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area. (2019) (28)
- Ascaris Larval Infection and Lung Invasion Directly Induce Severe Allergic Airway Disease in Mice (2018) (28)
- Expression, purification, and characterization of the Necator americanus aspartic protease-1 (Na-APR-1 (M74)) antigen, a component of the bivalent human hookworm vaccine (2015) (28)
- Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico (2018) (27)
- Potency testing for the experimental Na-GST-1 hookworm vaccine (2010) (27)
- Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response (2017) (26)
- Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting. (2016) (26)
- Will COVID-19 become the next neglected tropical disease? (2020) (26)
- Mechanisms of HTLV-1 transformation. (2004) (26)
- Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1 (2020) (26)
- Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens (2019) (25)
- A Scoping Review and Prevalence Analysis of Soil-Transmitted Helminth Infections in Honduras (2014) (23)
- Host Immunity and Inflammation to Pulmonary Helminth Infections (2020) (23)
- Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis (2020) (23)
- Biophysical and stabilization studies of the Chlamydia trachomatis mouse pneumonitis major outer membrane protein. (2009) (23)
- Repeat-driven generation of antigenic diversity in a major human pathogen Trypanosoma cruzi (2018) (22)
- Maintaining face mask use before and after achieving different COVID-19 vaccination coverage levels: a modelling study (2022) (22)
- Fusion of Na‐ASP‐2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti‐Na‐ASP‐2 IgE (2012) (22)
- Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission (2021) (22)
- Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease. (2017) (21)
- Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination (2021) (21)
- Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi (2021) (21)
- A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development (2018) (20)
- Bridging the innovation gap for neglected tropical diseases in México: capacity building for the development of a new generation of antipoverty vaccines (2011) (20)
- Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection (2016) (20)
- Ac-AP-12, a novel factor Xa anticoagulant peptide from the esophageal glands of adult Ancylostoma caninum. (2011) (20)
- An ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases (2006) (19)
- The silent and dangerous inequity around access to COVID-19 testing: A call to action (2021) (19)
- Trichuris muris whey acidic protein induces type 2 protective immunity against whipworm (2018) (18)
- A method to probe protein structure from UV absorbance spectra. (2019) (18)
- Central Latin America: Two decades of challenges in neglected tropical disease control (2020) (18)
- The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine (2021) (18)
- Identification of vaccine targets in pathogens and design of a vaccine using computational approaches (2021) (18)
- Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis (2013) (17)
- The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates (2016) (17)
- “Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action” (2019) (17)
- The human hookworm vaccine: recent updates and prospects for success (2015) (17)
- Identification of immunodominant antigens for the laboratory diagnosis of toxocariasis (2015) (17)
- The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice (2016) (16)
- Immunogenicity of the Hookworm Na-ASP-2 Vaccine Candidate: Characterization of Humoral and Cellular Responses after Vaccination in the Sprague Dawley Rat (2005) (16)
- Goud, G. N. et al. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine 23, 4754-4764 (2005) (15)
- Coronavirus vaccine-associated lung immunopathology-what is the significance? (2020) (15)
- Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm (2008) (15)
- Ligand binding properties of two Brugia malayi fatty acid and retinol (FAR) binding proteins and their vaccine efficacies against challenge infection in gerbils (2018) (14)
- New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74 (2015) (14)
- Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial. (2020) (14)
- Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy (2017) (13)
- Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients. (2019) (13)
- Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection (2020) (13)
- Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection (2021) (13)
- Ears of the Armadillo: Global Health Research and Neglected Diseases in Texas (2013) (13)
- The Factor H-Binding Site of CspZ as a Protective Target against Multistrain, Tick-Transmitted Lyme Disease (2020) (12)
- China’s shifting neglected parasitic infections in an era of economic reform, urbanization, disease control, and the Belt and Road Initiative (2019) (12)
- Antibody responses against the vaccine antigens Ov-103 and Ov-RAL-2 are associated with protective immunity to Onchocerca volvulus infection in both mice and humans (2019) (12)
- Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate (2021) (12)
- Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy (2019) (12)
- Helminth infections of children: prospects for control. (2005) (12)
- TLR4 agonist protects against Trypanosoma cruzi acute lethal infection by decreasing cardiac parasite burdens (2020) (11)
- Advances in vaccines against neglected tropical diseases (2012) (11)
- Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis. (2017) (11)
- Expression of the c-ski proto-oncogene during cell cycle arrest and myogenic differentiation. (1995) (11)
- Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques. (2020) (11)
- Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24 (2016) (10)
- Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity (2021) (9)
- COVID-19 in the Americas and the erosion of human rights for the poor (2020) (9)
- The Gulf of Mexico: A “Hot Zone” for Neglected Tropical Diseases? (2015) (9)
- Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine (2017) (9)
- Vaccination with chimeric protein induces protection in murine model against ascariasis. (2020) (9)
- Preparing for SARS-CoV-2 Vaccines in US Immigrant Communities: Strategies for Allocation, Distribution, and Communication. (2020) (9)
- Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study (2021) (8)
- Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice (2021) (8)
- Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties (2016) (8)
- Identification, Characterization, and Structure of Tm16 from Trichuris muris (2017) (8)
- How Efficacious Must a COVID-19 Coronavirus Vaccine be to Prevent or Stop an Epidemic by Itself (2020) (8)
- Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment (2021) (8)
- Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant (2021) (8)
- Vaccines against neglected tropical diseases: promising interventions to rescue the poorest populations in the Americas. (2014) (7)
- Urgent needs to accelerate the race for COVID-19 therapeutics (2021) (7)
- Cloning, Expression and Biophysical Characterization of a Yeast-expressed Recombinant SARS-CoV-2 Receptor Binding Domain COVID-19 Vaccine Candidate (2020) (7)
- Use of Multi-Parallel Real-Time Quantitative PCR to Determine Blastocystis Prevalence and Association with Other Gastrointestinal Parasite Infection in a Rural Honduran Location. (2020) (7)
- Alterations to the cardiac metabolome induced by chronic T. cruzi infection relate to the degree of cardiac pathology (2020) (7)
- A new patient registry for Chagas disease (2020) (7)
- Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis (2017) (7)
- In vitro cultured peripheral blood mononuclear cells from patients with chronic schistosomiasis mansoni show immunomodulation of cyclin D1,2,3 in the presence of soluble egg antigens. (2007) (7)
- An extensive survey of molecular docking tools and their applications using text mining and deep curation strategies. (2019) (6)
- Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi (2021) (6)
- Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed (2021) (6)
- Process Characterization and Biophysical Analysis for a Yeast-Expressed Phlebotomus papatasi Salivary Protein (PpSP15) as a Leishmania Vaccine Candidate (2020) (6)
- The parasite-derived rOv-ASP-1 is an effective antigen-sparing CD4+ T cell-dependent adjuvant for the trivalent inactivated influenza vaccine, and functions in the absence of MyD88 pathway. (2018) (6)
- Limited antigenic variation in the Trypanosoma cruzi candidate vaccine antigen TSA‐1 (2014) (6)
- The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission. (2020) (5)
- Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice (2022) (5)
- A research capacity strengthening project for infectious diseases in Honduras: experience and lessons learned. (2013) (5)
- Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy (2021) (5)
- Advances in vaccine development for human trichuriasis (2021) (5)
- A research capacity strengthening project for infectious diseases in Honduras: experience and lessons learned (2013) (5)
- Vaccines Linked to Chemotherapy: A New Approach to Control Helminth Infections (2012) (4)
- Controlled Infection of Humans with the Hookworm Parasite Necator americanus to Accelerate Vaccine Development : The Human Hookworm Vaccination/Challenge Model (HVCM). (2021) (4)
- Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern (2021) (4)
- Neglected Parasitic Infections and the Syndemic Anemia Vaccines for Africa (2019) (4)
- Mining the Metabolome for New and Innovative Chagas Disease Treatments. (2020) (3)
- Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis (2017) (3)
- Covalent vaccination with Trypanosoma cruzi Tc24 induces catalytic antibody production (2018) (3)
- A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis. (2020) (3)
- Potency testing for a recombinant protein vaccine early in clinical development: Lessons from the Schistosoma mansoni Tetraspanin 2 vaccine (2021) (3)
- Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concern (2022) (3)
- Expression, purification, crystallization and preliminary X-ray analysis of a truncated soluble domain of human glioma pathogenesis-related protein 1. (2010) (3)
- Advancing a Human Onchocerciasis Vaccine From Antigen Discovery to Efficacy Studies Against Natural Infection of Cattle With Onchocerca ochengi (2022) (3)
- Vaxi-DL: A web-based deep learning server to identify potential vaccine candidates (2022) (3)
- Transient Ascaris suum larval migration induces intractable chronic pulmonary disease and anemia in mice (2021) (3)
- Biochemical Screening of Potent Zika Virus Protease Inhibitors (2022) (2)
- Alterations to the Cardiac Metabolome Induced by Chronic T. cruzi Infection Relate to the Degree of Cardiac Pathology. (2021) (2)
- Mucosal Vaccination With Recombinant Tm-WAP49 Protein Induces Protective Humoral and Cellular Immunity Against Experimental Trichuriasis in AKR Mice (2022) (2)
- Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon (2021) (2)
- Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc 24 (2015) (2)
- Potential for Developing the SARS-CoV Receptor Binding Domain Recombinant Protein (RBD) as a Heterologous Human Vaccine for SARS-CoV-2 (2020) (2)
- Response to `letter to the editor: ‘Strategies to enhance access to diagnosis and treatment for Chagas disease patients in Latin America’´ (2019) (2)
- Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis (2022) (2)
- PLOS Neglected Tropical Diseases 2016 Reviewer and Editorial Board Thank You (2017) (1)
- A simple fluorescence-based assay for quantification of the Toll-Like Receptor agonist E6020 in vaccine formulations. (2017) (1)
- NEW HAZELNUT HYBRIDS (1994) (1)
- ASCVac-1, a Multi-Peptide Chimeric Vaccine, Protects Mice Against Ascaris suum Infection (2021) (1)
- Should we vaccinate against long-COVID? (2022) (1)
- Diversity, Equity, and Inclusion in the Microbial Sciences—the Texas Perspective (2021) (1)
- Hookworm infection. (1968) (1)
- Reproductive Outcomes in Rhesus Macaques (Macaca mulatta) with Naturally-acquired Trypanosoma cruzi Infection. (2020) (1)
- Inspiring women scientists in Honduras (2019) (1)
- Why vaccinate children against COVID-19? (2022) (1)
- A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice. (2022) (1)
- Poverty associated with the environmental contamination of gastrointestinal parasites in the Southern United States (2023) (1)
- Identification , Characterization , and Structure of Tm 16 from Trichuris muris (2017) (1)
- Estimation of the morbidity and mortality of congenital Chagas disease: A systematic review and meta-analysis (2022) (1)
- The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age. (2020) (0)
- A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area (2023) (0)
- Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon (2022) (0)
- Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-naïve adults (2022) (0)
- 2257 (2017) (0)
- I Never Thought I Had “Moral Courage,” until COVID-19 Happened (2020) (0)
- Preclinical advances and the immunophysiology of a new therapeutic Chagas disease vaccine (2022) (0)
- Onchocerca volvulus bivalent subunit vaccine induces protective immunity in genetically diverse collaborative cross recombinant inbred intercross mice (2021) (0)
- 31 Emerging Pandemic Infectious Disease Threats (2023) (0)
- Cover Image (2018) (0)
- COVID-19 vaccine design: the Janus face of immune enhancement (2020) (0)
- Role of the Extracellular Matrix and Cytoskeleton in the Regulation of Cyclins, Cyclindependent Kinase Inhibitors, and Anchorage-Dependent Growth (1997) (0)
- 2257: Vaccine efficacy and immunogenicity of recombinant WAP and CAP-1 proteins in AKR mice (2017) (0)
- Immunological characterization of human hosts to Ascaris lumbricoides and Trichuris trichiura infection in a population living in the rural municipality of Colomoncagua, Honduras (MPF6P.654) (2015) (0)
- The hookworm Ancylostoma ceylanicum intestinal transcriptome provides a platform for selecting drug and vaccine candidates (2016) (0)
- Vaccines and therapeutics for immunocompromised patients with COVID-19 (2023) (0)
- Reviewing a Decade of Outpatient Tropical Medicine in Houston, Texas (2022) (0)
- Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults (2020) (0)
- Potency Testing for NTD Vaccines: Determining Relative Potency for the Na-GST-1 Human Hookworm Vaccine (2011) (0)
- Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease (2023) (0)
- BM2L is a spontaneous leukemogenic variant of a non-leukemogenic v-myb-transformed myeloid cell line. (1993) (0)
- Development of scalable manufacturing process and GMP-compatible formulation for a novel recombinant schistosomiasis vaccine (2018) (0)
- CspZ FH-Binding Sites as Epitopes Promote Antibody-Mediated Lyme Borreliae Clearance (2022) (0)
- Creating a Culture of Public Engagement and Promoting Global Health (2018) (0)
- Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights (2022) (0)
- Excretory/Secretory Proteome of Females and Males of the Hookworm Ancylostoma ceylanicum (2023) (0)
- Localized cardiac metabolic trajectories and post-infectious metabolic sequelae in experimental Chagas disease (2023) (0)
- Consequences of Cyclin D1/BRCA1 Interaction in Breast Cancer Progression (2005) (0)
- A Data-Driven Approach to Construct a Molecular Map of Trypanosoma cruzi to Identify Drugs and Vaccine Targets (2023) (0)
- Urinary schistosomiasis in Guinea Bissau (2015) (0)
- Human Schistosomiasis Vaccines as Next Generation Control Tools (2023) (0)
- Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in BALB/c mice (2022) (0)
- Comparative Immunogenicity of Na-GST-1 Human Hookworm Vaccine with Synthetic Glucopyranosyl Lipid Adjuvant (GLA) in BALB/c Mice (2011) (0)
- Shiny New Toys and Matchbox Cars: Vaccine Diplomacy Requires Balancing Emerging and Traditional Technologies (2022) (0)
- Human Hookworm Disease: Alternative Strategies to Achieve the Global Health Agenda for Elimination (2017) (0)
- A robust and reproducible process for production of a schistosomiasis vaccine (2013) (0)
- A short-term method to evaluate anti-leishmania drugs by inhibition of stage differentiation in Leishmania mexicana using flow cytometry. (2023) (0)
- Current Tropical Medicine Reports: A Path Forward to Highlight Research and Clinical Advances, New Trends and Innovations (2014) (0)
- Global Health and Tropical Medicine in the Twenty-First Century: A Renewed Interest in the Understanding and the Control of Helminth Infections (2015) (0)
- Microbiome Alterations Driven by Trypanosoma cruzi Infection in Two Disjunctive Murine Models (2023) (0)
- AWARD NUMBER: DAMD17-03-1-0198 TITLE: Consequences of Cyclin D1/BRCA1 Interaction in Breast Cancer Progression (2006) (0)
This paper list is powered by the following services:
Other Resources About Maria Elena Bottazzi
What Schools Are Affiliated With Maria Elena Bottazzi?
Maria Elena Bottazzi is affiliated with the following schools:
